西班牙改善心血管健康和治疗血脂异常的策略。专家见解项目。

IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE
Juan Pedro-Botet, Román Freixa, Juan José Tamarit, José López-Miranda, Rosa Fernández-Olmo, Ovidio Muñiz-Grijalvo, Rafael Vázquez-García, Carlos Guijarro, Luis Rodríguez-Padial, José Luis Díaz-Díaz, Marisol Bravo-Amaro, José Luís Hernández, José Antonio Alarcón-Duque, José Alfredo Martin-Armas, Martín García-López, Juan Cosín-Sales
{"title":"西班牙改善心血管健康和治疗血脂异常的策略。专家见解项目。","authors":"Juan Pedro-Botet, Román Freixa, Juan José Tamarit, José López-Miranda, Rosa Fernández-Olmo, Ovidio Muñiz-Grijalvo, Rafael Vázquez-García, Carlos Guijarro, Luis Rodríguez-Padial, José Luis Díaz-Díaz, Marisol Bravo-Amaro, José Luís Hernández, José Antonio Alarcón-Duque, José Alfredo Martin-Armas, Martín García-López, Juan Cosín-Sales","doi":"10.1016/j.arteri.2024.08.007","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To gather opinions, recommendations, and proposals for improvement from Spanish clinicians on cardiovascular (CV) health, with particular focus on dyslipidemia management.</p><p><strong>Methods: </strong>The Expert Insights project involved 8face-to-face sessions held throughout Spain, attended by 138 CV health experts. Clinicians answered to 25 questions survey related to CV health and dyslipidemia control. Each session included an analysis and a discussion on the perceived realities and areas for improvement.</p><p><strong>Results: </strong>72% of centers have a standardized process for monitoring patients after a CV episode at discharge, but only 37% during their clinical follow-up. Patient care and management are dependent on the physician, with a lack of coordination between hospital specialties and primary care (PC). 95% of clinicians believe it is necessary to standarize treatment optimization. 65% of centers prescribe combined lipid-lowering treatment after a CV episode. Updating cLDL levels in the Therapeutic Positioning Report and standardizing and globalizing the prescription document would reduce iPCSK9 prescription barriers and lead to more equitable access.</p><p><strong>Conclusions: </strong>In Spain, there are significant deficiencies in the management of dyslipidemia, with a great need for a consensus on standardizing management processes and optimizing patient treatment. The opinions, recommendations, and improvement proposals from Spanish clinicians on CV health are an important starting point to improve the situation.</p>","PeriodicalId":45230,"journal":{"name":"Clinica e Investigacion en Arteriosclerosis","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Strategies to improve cardiovascular health and treatment of dyslipidemia in Spain. Expert Insights Project.\",\"authors\":\"Juan Pedro-Botet, Román Freixa, Juan José Tamarit, José López-Miranda, Rosa Fernández-Olmo, Ovidio Muñiz-Grijalvo, Rafael Vázquez-García, Carlos Guijarro, Luis Rodríguez-Padial, José Luis Díaz-Díaz, Marisol Bravo-Amaro, José Luís Hernández, José Antonio Alarcón-Duque, José Alfredo Martin-Armas, Martín García-López, Juan Cosín-Sales\",\"doi\":\"10.1016/j.arteri.2024.08.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To gather opinions, recommendations, and proposals for improvement from Spanish clinicians on cardiovascular (CV) health, with particular focus on dyslipidemia management.</p><p><strong>Methods: </strong>The Expert Insights project involved 8face-to-face sessions held throughout Spain, attended by 138 CV health experts. Clinicians answered to 25 questions survey related to CV health and dyslipidemia control. Each session included an analysis and a discussion on the perceived realities and areas for improvement.</p><p><strong>Results: </strong>72% of centers have a standardized process for monitoring patients after a CV episode at discharge, but only 37% during their clinical follow-up. Patient care and management are dependent on the physician, with a lack of coordination between hospital specialties and primary care (PC). 95% of clinicians believe it is necessary to standarize treatment optimization. 65% of centers prescribe combined lipid-lowering treatment after a CV episode. Updating cLDL levels in the Therapeutic Positioning Report and standardizing and globalizing the prescription document would reduce iPCSK9 prescription barriers and lead to more equitable access.</p><p><strong>Conclusions: </strong>In Spain, there are significant deficiencies in the management of dyslipidemia, with a great need for a consensus on standardizing management processes and optimizing patient treatment. The opinions, recommendations, and improvement proposals from Spanish clinicians on CV health are an important starting point to improve the situation.</p>\",\"PeriodicalId\":45230,\"journal\":{\"name\":\"Clinica e Investigacion en Arteriosclerosis\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica e Investigacion en Arteriosclerosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.arteri.2024.08.007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Arteriosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.arteri.2024.08.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

目的:收集西班牙临床医生对心血管健康的意见、建议和改进意见:收集西班牙临床医生对心血管(CV)健康,尤其是血脂异常管理的意见、建议和改进方案:专家视角 "项目在西班牙各地举行了 8 次面对面会议,共有 138 名心血管健康专家参加。临床医生回答了与 CV 健康和血脂异常控制有关的 25 个问题。每次会议都包括对现实情况和有待改进之处的分析和讨论:结果:72%的中心在患者出院后对其进行了标准化的监测,但只有 37% 的中心在临床随访期间对患者进行了监测。患者护理和管理依赖于医生,医院专科和初级保健(PC)之间缺乏协调。95% 的临床医生认为有必要将治疗优化标准化。65%的医疗中心在冠心病发作后处方联合降脂治疗。更新《治疗定位报告》中的 cLDL 水平,实现处方文件的标准化和全球化,将减少 iPCSK9 处方障碍,使患者更公平地获得治疗:西班牙在血脂异常管理方面存在严重缺陷,亟需就规范管理流程和优化患者治疗达成共识。西班牙临床医生对心血管健康的意见、建议和改进方案是改善现状的重要起点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Strategies to improve cardiovascular health and treatment of dyslipidemia in Spain. Expert Insights Project.

Objectives: To gather opinions, recommendations, and proposals for improvement from Spanish clinicians on cardiovascular (CV) health, with particular focus on dyslipidemia management.

Methods: The Expert Insights project involved 8face-to-face sessions held throughout Spain, attended by 138 CV health experts. Clinicians answered to 25 questions survey related to CV health and dyslipidemia control. Each session included an analysis and a discussion on the perceived realities and areas for improvement.

Results: 72% of centers have a standardized process for monitoring patients after a CV episode at discharge, but only 37% during their clinical follow-up. Patient care and management are dependent on the physician, with a lack of coordination between hospital specialties and primary care (PC). 95% of clinicians believe it is necessary to standarize treatment optimization. 65% of centers prescribe combined lipid-lowering treatment after a CV episode. Updating cLDL levels in the Therapeutic Positioning Report and standardizing and globalizing the prescription document would reduce iPCSK9 prescription barriers and lead to more equitable access.

Conclusions: In Spain, there are significant deficiencies in the management of dyslipidemia, with a great need for a consensus on standardizing management processes and optimizing patient treatment. The opinions, recommendations, and improvement proposals from Spanish clinicians on CV health are an important starting point to improve the situation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinica e Investigacion en Arteriosclerosis
Clinica e Investigacion en Arteriosclerosis PERIPHERAL VASCULAR DISEASE-
CiteScore
3.20
自引率
6.20%
发文量
44
审稿时长
40 days
期刊介绍: La publicación idónea para acceder tanto a los últimos originales de investigación como a formación médica continuada sobre la arteriosclerosis y su etiología, epidemiología, fisiopatología, diagnóstico y tratamiento. Además, es la publicación oficial de la Sociedad Española de Arteriosclerosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信